- Home
- CRBP vs ALTS Comparison
CRBP vs ALTS Comparison
Compare CRBP & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- ALTS
- Stock Information
- Founded
- CRBP 2009
- ALTS 1976
- Country
- CRBP United States
- ALTS United States
- Employees
- CRBP N/A
- ALTS N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- CRBP Health Care
- ALTS
- Exchange
- CRBP Nasdaq
- ALTS NYSE
- Market Cap
- CRBP 73.4M
- ALTS 66.5M
- IPO Year
- CRBP N/A
- ALTS N/A
- Fundamental
- Price
- CRBP $5.31
- ALTS $3.88
- Analyst Decision
- CRBP Strong Buy
- ALTS
- Analyst Count
- CRBP 10
- ALTS 0
- Target Price
- CRBP $60.89
- ALTS N/A
- AVG Volume (30 Days)
- CRBP 213.2K
- ALTS 140.9K
- Earning Date
- CRBP 03-11-2025
- ALTS 03-28-2025
- Dividend Yield
- CRBP N/A
- ALTS N/A
- EPS Growth
- CRBP N/A
- ALTS N/A
- EPS
- CRBP N/A
- ALTS N/A
- Revenue
- CRBP N/A
- ALTS $12,532,000.00
- Revenue This Year
- CRBP N/A
- ALTS N/A
- Revenue Next Year
- CRBP $270.01
- ALTS N/A
- P/E Ratio
- CRBP N/A
- ALTS N/A
- Revenue Growth
- CRBP N/A
- ALTS N/A
- 52 Week Low
- CRBP $5.12
- ALTS $1.29
- 52 Week High
- CRBP $61.90
- ALTS $7.75
- Technical
- Relative Strength Index (RSI)
- CRBP 27.45
- ALTS 35.54
- Support Level
- CRBP $5.76
- ALTS $4.15
- Resistance Level
- CRBP $6.17
- ALTS $4.58
- Average True Range (ATR)
- CRBP 0.39
- ALTS 0.44
- MACD
- CRBP 0.03
- ALTS -0.04
- Stochastic Oscillator
- CRBP 9.73
- ALTS 3.01
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.